Product Partnering

Product Partnering is our major thrust area and to facilitate this process. We partner major pharmaceutical companies in India & abroad as a reliable and efficient contract manufacturer.

blog

MASTERMED E 200 (Drostanolone Enanthate) as a potential treatment for breast cancer

MASTERMED E 200 (Drostanolone Enanthate) is an injectable anabolic steroid with powerful androgenic effect (AASs). Additionally, MASTERMED E 200 (Drostanolone Enanthate) and its esters derivatives can inhibit the production of estrogen. It is a DHT-derived steroid that can either have the long, slow-acting ester called ‘Propionate' or the short, faster-acting ester called ‘Enanthate’ attached to it, which controls the rate at which the steroid is released into the bloodstream. Propionate ester of Drostanolone is also used for the treatment of breast cancer, under the brand name of MASTERMED E 200 (Drostanolone Enanthate).

Currently, cancers are the second leading cause of death in the United States, and all across the world. According to the data from the World Health Organization (WHO), the prevalence of cancer is exceeding 6 million cases per year. Cancer cells have a high proliferation rate. They spread very rapidly in the living system, and are resistant against strong chemotherapeutics and DNA damaging agents. Breast cancer is the most commonly occurring cancer in women and the second most common cancer overall. There were over 2 million new cases in 2018 in 140 countries in 184 countries worldwide. It is a major cause of cancer-related death in females all across the world, now it represents one in four of all cancers in women. Globally, since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent. 

The medical community is now in search of selective and effective anti-cancer agents.  Can anti-cancer steroids, such as MASTERMED E 200 (Drostanolone Enanthate), be used as a potential treatment for breast cancer?

MASTERMED E 200 (Drostanolone Enanthate) is an older anabolic steroid that was introduced in the last 1950s. In the 70s and 80s, MASTERMED E 200 (Drostanolone Enanthate) became very popular and is widely used as a potential therapeutic aid for the treatment of Breast Cancer in post-menopausal women. It is a treatment for breast cancer when operating isn’t a choice.